Articles

Pulmonary Hypertension with Lung Disease

by Kevin Smith Business Information.

Brief description of study

Researchers at the University of Kentucky are conducting a study to investigate the safety and how well the inhaled investigational drug treprostinil works in people with pulmonary hypertension associated with lung disease. This study will look at your ability to exercise after taking the study drug.

You may be eligible to participate if you:
-Are 18 years of age or older;
-Do not have a history of drug abuse;
-Are able to walk for 6-minutes; and
-Do not have diabetes.

Participants will be compensated for your time.

For more information, please contact:
Ketan Buch, MD
kpbuch0@uky.edu
or
Research coordinator:
859-218-6740


Sponsor Ads


About Kevin Smith Innovator   Business Information.

18 connections, 0 recommendations, 72 honor points.
Joined APSense since, October 6th, 2018, From New York, United States.

Created on Jan 10th 2019 00:17. Viewed 347 times.

Comments

No comment, be the first to comment.
Please sign in before you comment.